SARS-CoV-2-assoziierte Todesfälle innerhalb des ersten Jahres der COVID-19-Pandemie: eine Autopsiestudie

[1]  M. Monreal,et al.  Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study , 2022, Research and practice in thrombosis and haemostasis.

[2]  Jaime Martín-Martín,et al.  Comorbidities and autopsy findings of COVID-19 deaths and their association with time to death: a systematic review and meta-analysis , 2022, Current medical research and opinion.

[3]  K. Zatloukal,et al.  Host and microbiome features of secondary infections in lethal covid-19 , 2022, iScience.

[4]  H. Moch,et al.  Long-Term Persisting SARS-CoV-2 RNA and Pathological Findings: Lessons Learnt From a Series of 35 COVID-19 Autopsies , 2022, Frontiers in Medicine.

[5]  I. Kern,et al.  COVID-19 Pulmonary Pathology: The Experience of European Pulmonary Pathologists throughout the First Two Waves of the Pandemic , 2022, Diagnostics.

[6]  A. van Rossum,et al.  Cardiac inflammation and microvascular procoagulant changes are decreased in second wave compared to first wave deceased COVID-19 patients , 2021, International Journal of Cardiology.

[7]  A. Zoufaly,et al.  Low-molecular-weight heparin use in coronavirus disease 2019 is associated with curtailed viral persistence: a retrospective multicentre observational study , 2021, Cardiovascular research.

[8]  M. Aepfelbacher,et al.  Prospective postmortem evaluation of 735 consecutive SARS-CoV-2-associated death cases , 2021, Scientific Reports.

[9]  F. Scholkmann,et al.  Autopsy-Based Pulmonary and Vascular Pathology: Pulmonary Endotheliitis and Multi-Organ Involvement in COVID-19 Associated Deaths , 2021, Respiration.

[10]  T. Glasz,et al.  A COVID-19-association-dependent categorization of death causes in 100 autopsy cases , 2021, GeroScience.

[11]  O. Wichmann,et al.  Pre-existing health conditions and severe COVID-19 outcomes: an umbrella review approach and meta-analysis of global evidence , 2021, BMC Medicine.

[12]  W. Haas,et al.  Die verschiedenen Phasen der COVID-19-Pandemie in Deutschland: Eine deskriptive Analyse von Januar 2020 bis Februar 2021 , 2021, Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz.

[13]  S. Madhi,et al.  Clinical characteristics and histopathology of COVID-19 related deaths in South African adults , 2021, PloS one.

[14]  F. Heppner,et al.  Causes of death and comorbidities in hospitalized patients with COVID-19 , 2021, Scientific Reports.

[15]  A. Esmaeilzadeh,et al.  COVID‐19: Virology, biology and novel laboratory diagnosis , 2020, The journal of gene medicine.

[16]  C. Radu,et al.  Post-Mortem Diagnosis and Autopsy Findings in SARS-CoV-2 Infection: Forensic Case Series , 2020, Diagnostics.

[17]  Mathias W Pletz,et al.  Bone marrow haemophagocytosis indicates severe infection with severe acute respiratory syndrome coronavirus 2 , 2020, Histopathology.

[18]  G. Ippolito,et al.  Postmortem Findings in Italian Patients With COVID-19: A Descriptive Full Autopsy Study of Cases With and Without Comorbidities , 2020, The Journal of infectious diseases.

[19]  J. Sperhake Autopsies of COVID-19 deceased? Absolutely! , 2020, Legal Medicine.

[20]  L. Moore,et al.  COVID-19 autopsy in people who died in community settings: the first series , 2020, Journal of Clinical Pathology.

[21]  M. Aepfelbacher,et al.  Dying with SARS-CoV-2 infection—an autopsy study of the first consecutive 80 cases in Hamburg, Germany , 2020, International Journal of Legal Medicine.

[22]  R. Claus,et al.  Postmortem Examination of Patients With COVID-19. , 2020, JAMA.

[23]  K. Mertz,et al.  Postmortem examination of COVID‐19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction , 2020, Histopathology.

[24]  H. Neuhauser,et al.  Hypertension prevalence, awareness, treatment and control in Germany 1998 and 2008–11 , 2014, Journal of Human Hypertension.

[25]  H. Büller,et al.  Prevention of Deep Vein Thrombosis after Hip Replacement , 1999, Thrombosis and Haemostasis.